Desire-Focused Approach
May be considered when concerns involve reduced sexual desire rather than blood flow alone.
SEXUAL HEALTH
PT-141
INJECTION
PT-141, also known as bremelanotide, acts through melanocortin receptor pathways associated with sexual desire and arousal.
$229/month
All-inclusive pricing
All-inclusive pricing
Provider consultation, medication if prescribed, standard shipping, and applicable taxes are included. No insurance required.
Start AssessmentGet Started
Prescription treatment requires an online medical evaluation. A licensed provider determines whether treatment is clinically appropriate. Treatment is not guaranteed.
A different approach to desire, arousal, and intimate wellness.
PT-141, also known as bremelanotide, acts through melanocortin receptor pathways associated with sexual desire and arousal. It may be explored by eligible adults seeking a provider-guided option for concerns related to low desire, arousal, or sexual wellness.
A licensed medical provider reviews your medical and sexual-health history, symptoms, current medications, blood-pressure and cardiovascular history, relationship and psychological factors, and individual goals before determining whether PT-141 is appropriate.
- Desire-Focused Support
- Arousal Pathways
- Gender-Inclusive Evaluation
- Personalized Sexual Wellness
MEET PT-141
Sexual-wellness support that works through central signaling pathways.
PT-141 is also known as bremelanotide. It is a melanocortin receptor agonist that works through signaling pathways in the central nervous system associated with sexual desire and arousal.
This mechanism differs from medications such as sildenafil and tadalafil, which primarily affect blood-flow pathways involved in erectile response. PT-141 may therefore be discussed when a patient’s concerns involve desire or arousal rather than blood flow alone.
Sexual concerns can have physical, hormonal, psychological, medication-related, and relationship-related causes. A provider evaluates the broader picture before determining whether PT-141 or another treatment may be appropriate.
Individual response varies, and PT-141 does not guarantee increased desire, improved arousal, erections, orgasm, sexual satisfaction, or relationship improvement.
WHY PEOPLE EXPLORE PT-141
Personalized support for desire and arousal concerns.
Eligible adults may explore PT-141 as part of a provider-guided sexual-wellness plan. Treatment decisions should be based on the individual’s symptoms, medical history, medication use, cardiovascular health, and goals.
Arousal Pathway Support
Acts through melanocortin receptor pathways associated with sexual desire and arousal.
A Different Mechanism
Works differently from PDE5 inhibitors such as sildenafil and tadalafil, which primarily support erectile blood flow.
Inclusive Evaluation
May be discussed with eligible adults following an individualized provider assessment, while recognizing that approved indications and off-label prescribing considerations differ.
Personalized Sexual Wellness
Can be evaluated as one potential component of a broader plan addressing physical, hormonal, psychological, and medication-related factors.
Potential benefits vary and are not guaranteed. PT-141 should not be presented as an aphrodisiac that works for everyone, a guaranteed erection treatment, a cure for sexual dysfunction, or a substitute for appropriate medical or psychological care.
IS PT-141 RIGHT FOR YOU?
A private, individualized sexual-health evaluation.
PT-141 may be discussed with a provider by eligible adults experiencing concerns related to sexual desire, arousal, or intimate wellness. The provider evaluates the possible causes of the concern and determines whether PT-141, another medication, counseling, hormonal evaluation, or another approach may be more appropriate.
- Experiencing a meaningful change in sexual desire
- Interested in a treatment that does not primarily rely on erectile blood-flow pathways
- Seeking a private, provider-guided sexual-health evaluation
- Willing to discuss medications, cardiovascular health, and contributing factors
- Comfortable following a prescribed injectable treatment plan
Your provider will review your blood pressure, cardiovascular history, medications, allergies, pregnancy or breastfeeding status, sexual-health symptoms, mental-health history, hormonal considerations, and personal treatment goals.
PT-141 may not be appropriate for individuals with uncontrolled high blood pressure or certain cardiovascular conditions. Eligibility must be determined by the licensed prescribing provider.
THE SCIENCE
A central pathway rather than a blood-flow-first approach.
Bremelanotide is a melanocortin receptor agonist. Its exact mechanism for improving symptoms of low sexual desire is not fully established, but it acts through central nervous system pathways associated with desire and arousal.
This differs from sildenafil and tadalafil, which inhibit PDE5 and primarily help support blood flow involved in erectile response.
- 01
Melanocortin Signaling
PT-141 activates melanocortin receptor pathways within the central nervous system.
- 02
Desire and Arousal Pathways
These pathways are associated with biological processes involved in sexual desire and arousal.
- 03
Individual Response
A licensed provider evaluates whether this mechanism may be appropriate for the patient’s symptoms and medical history.
The mechanism does not guarantee a particular sexual response. Desire and arousal are influenced by physical health, hormones, mental health, relationships, medication effects, stress, sleep, and other individual factors.
DIFFERENT TREATMENT PATHWAYS
PT-141 is not the same as sildenafil or tadalafil.
PT-141
- Injectable treatment
- Acts through central melanocortin signaling
- Explored for desire and arousal concerns
- Does not primarily work by increasing genital blood flow
- Eligibility and prescribed use are determined by a licensed provider
Sildenafil and Tadalafil
- Oral or dissolving formulations, depending on the prescribed product
- PDE5 inhibitors
- Primarily support erectile response through blood-flow pathways
- Do not directly treat every cause of reduced sexual desire
- Eligibility and prescribed use are determined by a licensed provider
One option is not universally better than the other. The appropriate treatment depends on the patient’s symptoms, anatomy, medical history, medication use, cardiovascular health, and provider evaluation. Patients should not combine PT-141 with another sexual-health medication unless specifically directed by the prescribing provider.
PERSONALIZED INJECTABLE CARE
A prescribed plan based on your individual needs.
If PT-141 is prescribed, the patient receives individualized instructions from the prescribing provider and dispensing pharmacy. The formulation, vial strength, dose, timing, frequency, preparation, storage, and administration instructions may vary.
Review Your Instructions
Read and follow every direction supplied by the prescribing provider and dispensing pharmacy.
Use Only as Prescribed
Do not change the amount, timing, or frequency without provider guidance.
Monitor Your Response
Pay attention to nausea, flushing, headache, blood-pressure-related symptoms, skin changes, or other unexpected reactions.
Contact Your Provider
Report persistent, worsening, severe, or concerning symptoms promptly.
A universal PT-141 dose, injection timing, maximum frequency, vial strength, reconstitution method, or treatment schedule is not published here. These instructions come from the prescribing provider and dispensing pharmacy.
How it works
Three steps to personalized care.
Simple online care, reviewed by licensed medical providers.
- 01
Tell us about yourself
Complete a secure online health assessment so your provider can understand your goals, symptoms, and medical history.
- 02
Your provider reviews your care
A licensed medical provider evaluates your information and determines which treatment options may be clinically appropriate.
- 03
Begin your personalized plan
If prescribed, your treatment is delivered discreetly, with ongoing support and follow-up as needed.
What’s included
- Private online health assessment
- Licensed-provider consultation and medical review
- Medication if prescribed
- Ongoing treatment support
- Standard shipping
- Applicable taxes
- No separate membership fee
- Required injection supplies when provided with the prescription
Important Safety Information
- Do not use PT-141 if you have uncontrolled high blood pressure, heart disease, or an allergy to an ingredient in the dispensed medication.
- Tell your provider about your cardiovascular history and all medications you take. Tell them if you are pregnant, planning pregnancy, or breastfeeding.
- Common side effects may include nausea, flushing, headache, dizziness, tiredness, or injection-site reactions.
FREQUENTLY ASKED QUESTIONS
Questions about PT-141.
What is PT-141?
PT-141 is another name commonly used for bremelanotide, a melanocortin receptor agonist that acts through central nervous system pathways associated with sexual desire and arousal.
What is PT-141 explored for?
Eligible adults may explore PT-141 following provider evaluation for concerns related to sexual desire, arousal, and intimate wellness. Eligibility and expected benefits depend on the individual’s symptoms, medical history, and prescribed treatment.
Is PT-141 the same as Viagra or Cialis?
No. Sildenafil and tadalafil primarily support erectile response through blood-flow pathways. PT-141 acts through central melanocortin pathways associated with desire and arousal.
Can women and men be evaluated for PT-141?
A licensed provider may evaluate an adult patient’s sexual-health concerns and determine which treatments may be clinically appropriate. Approved indications, evidence, individual risks, and off-label prescribing considerations differ, so eligibility cannot be assumed based solely on gender.
Does PT-141 guarantee increased desire or arousal?
No. Individual responses vary, and desire and arousal may be affected by medical, hormonal, psychological, medication-related, and relationship factors. Outcomes are not guaranteed.
Does PT-141 require a prescription?
Yes. Treatment through Auva RX requires evaluation and approval by a licensed medical provider.
Can PT-141 be taken with sildenafil or tadalafil?
Patients should disclose all medications and sexual-health treatments to their provider. PT-141 should not be combined with another treatment unless the prescribing provider specifically determines that the combination is appropriate.
Will I need follow-up care?
The prescribing provider determines whether follow-up, blood-pressure review, treatment-response evaluation, or other monitoring is appropriate.
Explore related treatments.
Rapid-Dissolving Tablets
Lust
Women’s Sexual Wellness
Flibanserin + Oxytocin + L-Tyrosine
A personalized, provider-guided treatment option for eligible women experiencing concerns related to sexual desire and interest.
Oral Tablets
Sildenafil Oral Tablets
A familiar provider-prescribed oral treatment for erectile dysfunction, available through a private online medical assessment.
Oral Tablets
Tadalafil Oral Tablets
A provider-prescribed, longer-lasting oral treatment option for erectile dysfunction.
Ready to take a more personalized approach to sexual wellness?
Complete a private online assessment to help a licensed medical provider determine whether PT-141 may be appropriate for your medical history, symptoms, and personal goals.